Investor Relations

Company Description

News

Financial Reports

Financial Calendar

Presentations

The Share

New Issues

Corporate Governance

IR Contact

Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen

Dignitana CEO Catarina Mård Löwenadler will speak at the Aktiespararna Stora Aktiedagen on 29 November in Stockholm. Ms. Löwenadler’s 20-minute presentation begins at 1830 CET and will be streamed live. Event participants will have the opportunity to ask questions following her presentation.

Files for download
Dignitana Release - wkr0006.pdf

“Increased demand and high customer satisfaction continue to drive Dignitana’s growth. We have a clear strategy to raise awareness, affordbility and accessability that is built on demonstrated efficacy, scalable infrastructure, and competence in medical device and clinical operations,” said Catarina Mård Löwenadler. “This growth allows us to provide the life-changing DigniCap treatment to even more patients – and that is at the core of our mission.”

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.

You can stream the event live  on the Aktiespararna  YouTube channel  or  aktiespararna.se/tv/live. The following day the program will be published as a video on YouTube and at  aktiespararna.se/tv/evenemang.

Attendance to the event is free but space is limited so interested attendees may register here.  The audience may submit questions via SMS 079 347 98 45  or in the live chat connected to the video player.

The event is hosted by Aktiespararna, an independent organization working in the interest of private individuals who invest in stocks, mutual funds and other stock-related securities. The organization has more than 70,000 members and is a member of the World Federation of Investors which encompasses investors' organizations in 20 countries representing approximately 500,000 stock market investors.

For More Information Contact 

Melissa Bourestom, Chief Communications Officer,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.